Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

N. Mavaddat; D. Barrowdale; [No Value] et al; R.B. van der Luijt; M.G.E.M. Ausems; x HEBON; x CIMBA; A.C. Antoniou

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Translated title of the contribution: Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

N. Mavaddat
, D. Barrowdale
, [No Value] et al
, R.B. van der Luijt
, M.G.E.M. Ausems
, x HEBON
, x CIMBA
, A.C. Antoniou

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Original language	Undefined/Unknown
Pages (from-to)	134-147
Number of pages	14
Journal	Cancer Epidemiology Biomarkers & Prevention
Volume	21
Issue number	1
Publication status	Published - 2011

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22144499

Cite this

Mavaddat, N., Barrowdale, D., et al, N. V., van der Luijt, R. B., Ausems, M. G. E. M., HEBON, X., CIMBA, X., & Antoniou, A. C. (2011). Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology Biomarkers & Prevention, 21(1), 134-147. http://www.ncbi.nlm.nih.gov/pubmed/22144499

@article{0a2fca1c4f19430c89c6dc0bf5bdd70a,

title = "Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)",

author = "N. Mavaddat and D. Barrowdale and \{et al\}, \{[No Value]\} and \{van der Luijt\}, R.B. and M.G.E.M. Ausems and x HEBON and x CIMBA and A.C. Antoniou",

year = "2011",

language = "Undefined/Unknown",

volume = "21",

pages = "134--147",

journal = "Cancer Epidemiology Biomarkers \& Prevention",

issn = "1055-9965",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

Mavaddat, N, Barrowdale, D, et al, NV, van der Luijt, RB, Ausems, MGEM, HEBON, X, CIMBA, X & Antoniou, AC 2011, 'Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)', Cancer Epidemiology Biomarkers & Prevention, vol. 21, no. 1, pp. 134-147. <http://www.ncbi.nlm.nih.gov/pubmed/22144499>

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). / Mavaddat, N.; Barrowdale, D.; et al, [No Value] et al.
In: Cancer Epidemiology Biomarkers & Prevention, Vol. 21, No. 1, 2011, p. 134-147.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

AU - Mavaddat, N.

AU - Barrowdale, D.

AU - et al, [No Value]

AU - van der Luijt, R.B.

AU - Ausems, M.G.E.M.

AU - HEBON, x

AU - CIMBA, x

AU - Antoniou, A.C.

PY - 2011

Y1 - 2011

M3 - Article

SN - 1055-9965

VL - 21

SP - 134

EP - 147

JO - Cancer Epidemiology Biomarkers & Prevention

JF - Cancer Epidemiology Biomarkers & Prevention

IS - 1

ER -